1 concern was her health, Winfrey said, noting she doesn't live with a fear of death, but with "a conscious acknowledgment that it's possible at any time." "(I) recognize what an absolute miracle it is that 70 years on, that heart's still pumping," she added
Switching gears In mouse studies, when scientists blocked glucagon production, they expected insulin levels to drop
Synapses forming at rates that were previously unimaginable
In SURMOUNT-4, all participants received tirzepatide (Mounjaro, Eli Lilly) during a lead-in phase, with the study population achieving a mean weight loss of 20.2% at 36 weeks
Qualifications and eligibility criteria, such as age, health status, and medical history are considered per study for individuals interested in volunteering for Phase 1 trials